CAP-Malaria/Myanmar

File Type .pdf | File Size 646.03 KB

Myanmar accounts for more than half of malaria cases and about three quarters of the malaria deaths in the region, with an estimated incidence around 465,000 confirmed cases in 2011 (VBDC Annual Report). The need for strengthened malaria control in Myanmar is made more urgent by evidence of artemisinin resistance parasites that have also been reported along the Myanmar-Thailand border. Monotherapy treatment of uncomplicated malaria is prevalent in most areas of the country. Counterfeit and substandard antimalarial medicines also reduce treatment success and increase drug resistance. Massive development projects and agri-businesses have resulted in large movement of populations from non-endemic to endemic areas in search of employment opportunities. Weak infrastructure and limited resources have created large gaps in malaria services, particularly in development areas and border areas.

Resource Type 
Promotional Materials
Fact Sheets
Regions/ Countries 
Language 
English